These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2202263)

  • 1. [Present and future of research in the diagnosis and treatment of cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990 Jun; 43(5):463-78. PubMed ID: 2202263
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of tumor-cell heterogeneity.
    Schnipper L
    N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
    [No Abstract]   [Full Text] [Related]  

  • 3. Proto-oncogenes, growth factor genes, receptor genes, differentiation genes and structural rearrangements in human cancer.
    De Braekeleer M
    Anticancer Res; 1988; 8(6):1325-8. PubMed ID: 2851290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomes, genes, and cancer.
    Nowell PC; Croce CM
    Am J Pathol; 1986 Oct; 125(1):7-15. PubMed ID: 3490792
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene amplification, drug resistance, and cancer.
    Schimke RT
    Cancer Res; 1984 May; 44(5):1735-42. PubMed ID: 6713376
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromosome rearrangements in oncogenesis.
    Nowell PC; Emanuel BS; Finan JB; Erikson J; Croce CM
    Microbiol Sci; 1984 Dec; 1(9):223-8. PubMed ID: 6444134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
    Brodeur GM
    Prog Hematol; 1986; 14():229-56. PubMed ID: 3003796
    [No Abstract]   [Full Text] [Related]  

  • 8. [Amplification of oncogenes in hematopoietic malignancies].
    Ohno H; Fukuhara S; Uchino H
    Nihon Rinsho; 1987 Dec; 45(12):2882-6. PubMed ID: 3446876
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug resistance and behavioural phenotype of cancer cells.
    Bashir I; Sikora K; Foster CS
    Cell Biol Int; 1993 Oct; 17(10):907-17. PubMed ID: 8287021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2: prevention of apoptosis as a mechanism of drug resistance.
    Reed JC
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):451-73. PubMed ID: 7642473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current emphasis in experimental cancer research and its relation to clinical oncology].
    Seeber S
    Onkologie; 1986 Oct; 9 Suppl 2():14, 17-9. PubMed ID: 3534669
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular interrelationships in multidrug resistance (review).
    Kellen JA
    Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogenes and tumor suppressor genes: therapeutic implications.
    Stass SA; Mixson J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2687-95. PubMed ID: 10068275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary bladder neoplasms].
    Shinohara N
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):38-42. PubMed ID: 19195117
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.
    Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD
    BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of hematologic malignancies.
    Yunis JJ; Tanzer J
    Crit Rev Oncog; 1993; 4(2):161-90. PubMed ID: 8420572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future clinical research on the use of BCG for bladder cancer.
    Morales A; Nickel JC
    Prog Clin Biol Res; 1989; 310():361-9. PubMed ID: 2771995
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure.
    Gazzaniga P; Gradilone A; Frati L; Aglianò AM
    Clin Cancer Res; 2001 Dec; 7(12):4288-9. PubMed ID: 11751531
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.